Probiodrug geht an die Amsterdamer Börse Euronext
This announcement is not an offer to sell, or a solicitation of an offer to acquire any securities. This announcement is not a prospectus and investors […]
Halle (Saale), Germany // Probiodrug AG, a developer of small molecule inhibitors for the treatment of inflammatory and neurodegenerative diseases, announced today that the United States […]